These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20738007)

  • 1. Neuropsychologic testing for chemotherapy-related cognitive impairment.
    Myers JS
    Adv Exp Med Biol; 2010; 678():55-69. PubMed ID: 20738007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An overview of the research of cancer-related cognitive impairment].
    Ferencz V; S Nagy Z; Tóth M
    Orv Hetil; 2019 Sep; 160(38):1495-1502. PubMed ID: 31537098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-related cognitive impairment.
    Myers JS
    Clin J Oncol Nurs; 2009 Aug; 13(4):413-21. PubMed ID: 19648097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncology nurse's perspective.
    Myers JS
    Adv Exp Med Biol; 2010; 678():13-8. PubMed ID: 20738001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging as a means of studying chemotherapy-related cognitive impairment.
    Raffa RB
    Adv Exp Med Biol; 2010; 678():70-6. PubMed ID: 20738008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
    Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
    Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.
    Craig CD; Monk BJ; Farley JH; Chase DM
    Support Care Cancer; 2014 Jan; 22(1):279-87. PubMed ID: 24212261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low neuropsychologic performance among adult cancer survivors treated with chemotherapy.
    Ferguson RJ; Ahles TA
    Curr Neurol Neurosci Rep; 2003 May; 3(3):215-22. PubMed ID: 12691626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
    Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
    Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemo fog: cancer chemotherapy-related cognitive impairment. Preface.
    Raffa RB; Tallarida RJ
    Adv Exp Med Biol; 2010; 678():vii-viii. PubMed ID: 20737998
    [No Abstract]   [Full Text] [Related]  

  • 11. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.
    Deprez S; Amant F; Smeets A; Peeters R; Leemans A; Van Hecke W; Verhoeven JS; Christiaens MR; Vandenberghe J; Vandenbulcke M; Sunaert S
    J Clin Oncol; 2012 Jan; 30(3):274-81. PubMed ID: 22184379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective or Objective Measures of Cognitive Functioning-What's More Important?
    Savard J; Ganz PA
    JAMA Oncol; 2016 Oct; 2(10):1263-1264. PubMed ID: 27441735
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
    Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
    J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-related cognitive impairment: the breast cancer experience.
    Myers JS
    Oncol Nurs Forum; 2012 Jan; 39(1):E31-40. PubMed ID: 22201666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.
    Vardy J; Rourke S; Tannock IF
    J Clin Oncol; 2007 Jun; 25(17):2455-63. PubMed ID: 17485710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is chemotherapy associated with cognitive impairment?
    Zachariae R; Mehlsen MY
    Nat Rev Urol; 2011 Apr; 8(4):182-3. PubMed ID: 21475329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of cognitive decline in people with cancer undergoing chemotherapy.
    Oh PJ
    Eur J Oncol Nurs; 2017 Apr; 27():53-59. PubMed ID: 28027862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
    J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
    [No Abstract]   [Full Text] [Related]  

  • 20. Future directions.
    Raffa RB; Tallarida RJ
    Adv Exp Med Biol; 2010; 678():165-7. PubMed ID: 20738019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.